Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 2Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Papillomavirus Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Paclitaxel 79Carboplatin 66pembrolizumab 61Bevacizumab 56Cisplatin 48Specimen Handling 29Drug Therapy 26Blood Specimen Collection 24Cyclophosphamide 20olaparib 19Taxes 17Magnetic Resonance Spectroscopy 16Letrozole 16Gemcitabine 16Biopsy 16liposomal doxorubicin 15niraparib 14fludarabine 14Brachytherapy 14Radiotherapy 13abemaciclib 12Topotecan 11Nivolumab 11Injections 11Doxorubicin 11lenvatinib 10Fluorouracil 10Surveys and Questionnaires 9Standard of Care 9Oxaliplatin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Human Papillomavirus Recombinant Vaccine nonavalent × Gynecologic × Clear all
NCT05266898 2025-04-18

AGO-Gard

Louisiana State University Health Sciences Center in New Orleans

Phase 4 Recruiting
250 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡